| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1285.1B | ¥1150.3B | +11.7% |
| Operating Income | ¥45.8B | ¥39.4B | +16.1% |
| Ordinary Income | ¥40.0B | ¥32.9B | +21.7% |
| Net Income | ¥33.2B | ¥23.7B | +40.4% |
| ROE | 7.5% | 5.8% | - |
FY2026 Q3 (nine-month cumulative) results: Revenue ¥128.5B (YoY +11.7%), Operating Income ¥4.6B (+16.1%), Ordinary Income ¥4.0B (+21.7%), Net Income ¥3.3B (+40.4%). The company achieved double-digit revenue growth with accelerated profit expansion. Operating margin reached 3.6%, representing a 0.3 percentage point improvement from 3.3% in the prior year period. Net income growth of 40.4% significantly outpaced revenue growth, partly attributable to a one-time gain on sale of fixed assets totaling ¥1.1B, which accounted for approximately 32.6% of the net income increase. The Device segment generated ¥114.0B in sales while the Solution segment contributed ¥14.5B. Full-year guidance projects revenue of ¥164.0B (+4.2% YoY), operating income of ¥5.5B (-5.0% YoY), and net income of ¥3.9B (-0.7% YoY), suggesting conservative expectations for Q4 performance.
[Profitability] ROE of 7.5% is composed of net profit margin 2.6%, asset turnover 1.497, and financial leverage 1.95x based on DuPont three-factor decomposition. Operating margin improved to 3.6% from 3.3% YoY (+0.3pt), while gross profit margin remained at 10.2%, indicating a low-margin business structure characteristic of the trading industry. Net profit margin of 2.6% benefited from extraordinary gains, with recurring profitability remaining constrained by the narrow gross margin profile. [Cash Quality] Cash and deposits stood at ¥7.9B against short-term borrowings of ¥22.0B, resulting in a cash-to-short-term debt ratio of 0.36x, indicating reliance on refinancing capabilities. [Investment Efficiency] Asset turnover of 1.497 reflects active asset utilization, though working capital efficiency shows room for improvement with days sales outstanding extending to approximately 117 days and cash conversion cycle reaching 128 days. [Financial Health] Equity ratio of 51.4% improved from 48.2% YoY (+3.2pt), demonstrating strengthened capital adequacy. Current ratio of 187.0% and quick ratio of 140.7% indicate adequate short-term liquidity on the surface. Debt-to-equity ratio of 0.95x remains within conservative levels, though the composition reveals 100% concentration in short-term debt, creating maturity mismatch concerns. Interest coverage ratio of 12.64x provides comfortable debt servicing capacity with interest expense of ¥0.4B.
Cash and deposits increased ¥0.5B YoY to ¥7.9B, representing a modest 6.8% growth that lagged behind the 40.4% net income expansion, suggesting working capital absorption or other cash outflows. Trade receivables rose ¥6.1B to ¥121.2B, extending DSO to approximately 117 days and indicating slower collection cycles that consumed operating cash. Inventories increased ¥1.8B to ¥53.7B, reflecting either strategic stock building or demand timing, with inventory days reaching approximately 52 days. Trade payables grew ¥5.2B to ¥62.6B, providing approximately 61 days of supplier credit and partially offsetting working capital needs. The net working capital increase of approximately ¥2.7B represents cash absorbed by business expansion. Short-term borrowings of ¥22.0B remain the primary funding source, with the cash coverage ratio of 0.36x highlighting dependence on continuous credit facility access. Total assets expanded ¥1.8B to ¥85.9B, driven by both working capital growth and operational scale-up. The gap between strong net income growth and modest cash accumulation warrants attention to working capital management efficiency and cash generation quality in subsequent periods.
Ordinary income of ¥4.0B versus operating income of ¥4.6B represents a net non-operating expense of approximately ¥0.6B, primarily comprising interest expense of ¥0.4B and foreign exchange losses of ¥0.4B. Non-operating expenses amount to 0.5% of revenue, reflecting financial costs from borrowing activities and currency headwinds. The company recorded extraordinary gains of ¥1.1B from sale of fixed assets, which contributed approximately 22.4% of pre-tax income of ¥4.8B and represents a significant non-recurring element. This one-time gain accounted for roughly 32.6% of the net income increase year-over-year, indicating that recurring operational improvements explain approximately two-thirds of profit growth while the remainder stems from asset monetization. The presence of substantial extraordinary gains raises questions about underlying earnings sustainability, as normalized earnings would be approximately ¥2.2B excluding this item. The low gross margin of 10.2% constrains recurring profitability and leaves limited buffer against cost pressures or competitive pricing. Without operating cash flow disclosure, the correlation between accrual-based earnings and cash generation cannot be verified, creating uncertainty about earnings quality from a cash conversion perspective.
Liquidity and refinancing risk: Short-term borrowings of ¥22.0B constitute 100% of interest-bearing debt, while cash holdings of ¥7.9B provide only 0.36x coverage. This maturity concentration creates vulnerability to credit market disruptions or tightening lending conditions, requiring continuous rollover of substantial short-term facilities. The mismatch between liquid assets and near-term obligations represents the most material financial risk.
Working capital efficiency deterioration: Days sales outstanding extended to 117 days with trade receivables growing faster than sales, while cash conversion cycle of 128 days indicates prolonged cash lock-up in operations. The ¥2.7B year-over-year increase in net working capital absorbs cash that could otherwise strengthen liquidity or reduce debt. Continued working capital expansion at this pace would strain financial flexibility and potentially necessitate additional external financing.
Earnings sustainability and margin pressure: Gross profit margin of 10.2% significantly constrains operating leverage, with net profit margin of 2.6% vulnerable to cost inflation or pricing competition. Extraordinary gains of ¥1.1B represented 32.6% of profit growth, meaning recurring operations delivered more modest improvement. Full-year guidance implies operating income decline of 5.0% and net income decline of 0.7%, suggesting Q4 challenges. The narrow margin structure provides limited cushion against adverse business conditions or further foreign exchange losses, which totaled ¥0.4B in the nine-month period.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 7.5% substantially exceeds industry median of 3.7% (2025-Q3) and positions in the upper quartile (IQR: 2.2%-8.4%), demonstrating superior capital efficiency relative to trading industry peers. Operating margin of 3.6% aligns closely with industry median of 3.2% (IQR: 1.3%-4.6%), indicating typical profitability structure for the sector. Net profit margin of 2.6% exceeds industry median of 2.0% (IQR: 1.0%-3.9%), placing the company in a favorable competitive position for bottom-line efficiency.
Financial Health: Equity ratio of 51.4% compares favorably to industry median of 47.8% (IQR: 43.0%-55.5%), reflecting above-average capital stability. Current ratio of 1.87x approximates industry median of 1.88x (IQR: 1.64x-2.38x), indicating standard short-term liquidity positioning. Financial leverage of 1.95x aligns precisely with industry median of 1.97x (IQR: 1.80-2.33x), suggesting typical capital structure leverage.
Efficiency: Asset turnover of 1.497 significantly exceeds industry median of 1.06 (IQR: 0.70-1.32), demonstrating superior asset utilization efficiency. Receivables turnover of 117 days is notably higher than industry median of 74 days (IQR: 65-91 days), indicating slower collection relative to peers and representing a competitive disadvantage. Inventory days of approximately 52 days compares favorably to industry median of 51 days (IQR: 31-75 days), showing adequate inventory management. Operating working capital days of approximately 128 days substantially exceeds industry median of 54 days (IQR: 37-96 days), highlighting material room for working capital efficiency improvement.
Growth: Revenue growth of 11.7% significantly outperforms industry median of 2.6% (IQR: -5.3% to 10.8%), positioning the company among top-quartile performers for top-line expansion in the trading sector.
(Industry: Trading (15 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis)
Strong revenue momentum with working capital efficiency as key value driver: The 11.7% revenue growth significantly exceeds the trading industry median of 2.6% and positions the company in the top quartile for expansion, driven by both Device segment scale (¥114.0B) and Solution segment contribution (¥14.5B). However, this growth has been accompanied by working capital absorption of approximately ¥2.7B year-over-year, with DSO extending to 117 days versus industry median of 74 days. The company's asset turnover of 1.497 exceeds industry median of 1.06, but operating working capital days of 128 substantially exceed the 54-day industry median. Improving receivables collection to industry-standard levels could release approximately ¥5-6B in cash, materially strengthening the balance sheet and reducing refinancing dependency.
Profitability quality constrained by margin structure and non-recurring gains: While ROE of 7.5% exceeds the 3.7% industry median, the 10.2% gross margin reflects the inherent constraints of the trading business model. Extraordinary gains of ¥1.1B from asset sales accounted for 32.6% of net income growth, indicating that sustainable operational improvement contributed approximately two-thirds of the profit increase. Operating margin of 3.6% aligns with industry median of 3.2%, offering limited operating leverage for margin expansion. The full-year guidance projecting operating income decline of 5.0% suggests management conservatism or anticipated Q4 headwinds, warranting monitoring of whether H1 momentum can be sustained through pricing discipline and cost management.
Liquidity structure requires active management despite adequate capital ratios: The concentration of 100% of interest-bearing debt in short-term borrowings (¥22.0B) against cash holdings of ¥7.9B creates a 0.36x coverage ratio, materially below prudent liquidity thresholds despite current ratio of 1.87x matching industry norms. This maturity mismatch represents vulnerability to credit market conditions, though interest coverage of 12.64x demonstrates comfortable debt servicing from operations. The equity ratio of 51.4% exceeds industry median of 47.8%, providing a capital cushion, but the high dividend payout ratio of 66.1% limits retained earnings accumulation for debt reduction. Optimal capital allocation would prioritize either extending debt maturity profile or accelerating working capital conversion to reduce refinancing dependency before maximizing shareholder distributions.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.